http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36478325

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Comment
endingPage 602
issn 1387-2877
1875-8908
issueIdentifier 2
pageRange 599-602
publicationName Journal of Alzheimer's disease : JAD
startingPage 599
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0ff5859bf6fbb0f867808edddf5df4eb
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fbf205ee316b679fee29721b59de9778
bibliographicCitation Norris CM. Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia? J Alzheimers Dis. 2023;95(2):599–602. doi: 10.3233/jad-230780. PMID: 37661889.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88a1130d4cbc1d9008999617d8d5a7e7
date 2023-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37661889
https://doi.org/10.3233/jad-230780
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Is It Time to Repurpose Calcineurin Inhibitors for the Treatment of Cognitive Impairment and Dementia?
discusses http://id.nlm.nih.gov/mesh/M0025261
http://id.nlm.nih.gov/mesh/M0587252
http://id.nlm.nih.gov/mesh/M0011171
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000544
http://id.nlm.nih.gov/mesh/D060825Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D007166Q000627
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D065095Q000627
http://id.nlm.nih.gov/mesh/D016559Q000627

Total number of triples: 32.